ID

35854

Beschreibung

The EvAluation of TaBlo In-CLinic and In-HOme; ODM derived from: https://clinicaltrials.gov/show/NCT02460263

Link

https://clinicaltrials.gov/show/NCT02460263

Stichworte

Versionen (1)
  1. 28.03.19 28.03.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

28. März 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility End Stage Renal Disease NCT02460263

Englisch

Eligibility End Stage Renal Disease NCT02460263

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject has end stage renal disease (esrd) adequately treated by maintenance dialysis achieving a kt/v ≥ 1.2 and has been deemed stable for at least three months by his/her treating nephrologist.
Beschreibung

Kidney Failure, Chronic | Maintenance Dialysis Kt/V | Study Subject Stable status

Datentyp

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2,1]
C0024501
UMLS CUI [2,2]
C0011946
UMLS CUI [2,3]
C0429662
UMLS CUI [3,1]
C0681850
UMLS CUI [3,2]
C0205360
subject has a well-functioning and stable vascular access that allows a blood flow of at least 300 ml/min.
Beschreibung

Vascular access Functioning Well Stable | Blood flow measurement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0750138
UMLS CUI [1,2]
C0542341
UMLS CUI [1,3]
C0205170
UMLS CUI [1,4]
C0205360
UMLS CUI [2]
C0005776
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
life expectancy less than 12 months from first study procedure.
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
subject has had a recent major cardiovascular adverse event within the last 3 months.
Beschreibung

Adverse event Cardiovascular Major

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C3887460
UMLS CUI [1,3]
C0205164
subject has new york class iii or iv congestive heart failure, or ejection fraction less than 30%.
Beschreibung

Congestive heart failure New York Heart Association Classification | Cardiac ejection fraction

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C1275491
UMLS CUI [2]
C0232174
subject with fluid overload due to intractable ascites secondary to liver cirrhosis.
Beschreibung

Fluid overload Due to Refractory ascites | Refractory ascites Secondary to Liver Cirrhosis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0546817
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C3532188
UMLS CUI [2,1]
C3532188
UMLS CUI [2,2]
C0175668
UMLS CUI [2,3]
C0023890
subject has uncontrolled blood pressure.
Beschreibung

Blood Pressure Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005823
UMLS CUI [1,2]
C0205318
subject is intolerant to heparin.
Beschreibung

Intolerance to Heparin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0019134
subject is seroreactive for hepatitis b surface antigen.
Beschreibung

Hepatitis B Surface Antigens Seropositive

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019168
UMLS CUI [1,2]
C0521143
subject has an active, life-threatening, rheumatologic disease.
Beschreibung

Rheumatism Life Threatening

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0035435
UMLS CUI [1,2]
C2826244
subject has a history of adverse reactions to dialyzer membrane material.
Beschreibung

Adverse reactions Dialyzer Membrane Materials

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0559546
UMLS CUI [1,2]
C0180409
UMLS CUI [1,3]
C1706182
UMLS CUI [1,4]
C0520510
subject is expected to receive an organ transplant during the course of the study.
Beschreibung

Organ Transplantation Expected

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0029216
UMLS CUI [1,2]
C1517001
subject has a life-threatening malignancy actively receiving treatment that would prevent successful completion of the study protocol.
Beschreibung

Malignant Neoplasms Life Threatening | Therapeutic procedure Preventing Completion Study Protocol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C2826244
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1292733
UMLS CUI [2,3]
C0205197
UMLS CUI [2,4]
C2348563
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility End Stage Renal Disease NCT02460263

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Kidney Failure, Chronic | Maintenance Dialysis Kt/V | Study Subject Stable status
Item
subject has end stage renal disease (esrd) adequately treated by maintenance dialysis achieving a kt/v ≥ 1.2 and has been deemed stable for at least three months by his/her treating nephrologist.
boolean
C0022661 (UMLS CUI [1])
C0024501 (UMLS CUI [2,1])
C0011946 (UMLS CUI [2,2])
C0429662 (UMLS CUI [2,3])
C0681850 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
Vascular access Functioning Well Stable | Blood flow measurement
Item
subject has a well-functioning and stable vascular access that allows a blood flow of at least 300 ml/min.
boolean
C0750138 (UMLS CUI [1,1])
C0542341 (UMLS CUI [1,2])
C0205170 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
C0005776 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Life Expectancy
Item
life expectancy less than 12 months from first study procedure.
boolean
C0023671 (UMLS CUI [1])
Adverse event Cardiovascular Major
Item
subject has had a recent major cardiovascular adverse event within the last 3 months.
boolean
C0877248 (UMLS CUI [1,1])
C3887460 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
Congestive heart failure New York Heart Association Classification | Cardiac ejection fraction
Item
subject has new york class iii or iv congestive heart failure, or ejection fraction less than 30%.
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C0232174 (UMLS CUI [2])
Fluid overload Due to Refractory ascites | Refractory ascites Secondary to Liver Cirrhosis
Item
subject with fluid overload due to intractable ascites secondary to liver cirrhosis.
boolean
C0546817 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3532188 (UMLS CUI [1,3])
C3532188 (UMLS CUI [2,1])
C0175668 (UMLS CUI [2,2])
C0023890 (UMLS CUI [2,3])
Blood Pressure Uncontrolled
Item
subject has uncontrolled blood pressure.
boolean
C0005823 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Intolerance to Heparin
Item
subject is intolerant to heparin.
boolean
C1744706 (UMLS CUI [1,1])
C0019134 (UMLS CUI [1,2])
Hepatitis B Surface Antigens Seropositive
Item
subject is seroreactive for hepatitis b surface antigen.
boolean
C0019168 (UMLS CUI [1,1])
C0521143 (UMLS CUI [1,2])
Rheumatism Life Threatening
Item
subject has an active, life-threatening, rheumatologic disease.
boolean
C0035435 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
Adverse reactions Dialyzer Membrane Materials
Item
subject has a history of adverse reactions to dialyzer membrane material.
boolean
C0559546 (UMLS CUI [1,1])
C0180409 (UMLS CUI [1,2])
C1706182 (UMLS CUI [1,3])
C0520510 (UMLS CUI [1,4])
Organ Transplantation Expected
Item
subject is expected to receive an organ transplant during the course of the study.
boolean
C0029216 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
Malignant Neoplasms Life Threatening | Therapeutic procedure Preventing Completion Study Protocol
Item
subject has a life-threatening malignancy actively receiving treatment that would prevent successful completion of the study protocol.
boolean
C0006826 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0205197 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video